These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 916813)

  • 1. In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists.
    Baudry M; Martres MP; Schwartz JC
    Life Sci; 1977 Oct; 21(8):1163-70. PubMed ID: 916813
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol.
    Schwartz JC; Baudry M; Martres MP; Costentin J; Protais P
    Life Sci; 1978 Oct; 23(17-18):1785-9. PubMed ID: 569235
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor binding in vivo: the feasibility of autoradiographic studies.
    Kuhar MJ; Murrin LC; Malouf AT; Klemm N
    Life Sci; 1978 Jan; 22(2):203-10. PubMed ID: 628311
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 6. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptors in rat frontal cortex: pharmacological properties in vivo and in vitro.
    Bacopoulos NG; Ware PL
    Life Sci; 1980 Dec 22-29; 27(25-26):2489-94. PubMed ID: 6163938
    [No Abstract]   [Full Text] [Related]  

  • 8. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vivo binding of tritiated agents in mouse brain].
    Baudry M; Martres MP; le Sellin M; Guyon A; Morgat JL; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(9):1001-4. PubMed ID: 411593
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
    Kazawa T; Mikuni M; Higuchi T; Arai I; Takahashi K; Yamauchi T
    Life Sci; 1990; 47(6):531-7. PubMed ID: 2402179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
    Burt DR; Creese I; Snyder SH
    Science; 1977 Apr; 196(4287):326-8. PubMed ID: 847477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
    Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
    J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide levels in the rat striatum and cerebellum--in vivo effects of dopamine and acetylcholine receptor agonists and antagonists.
    Puri SK; Choma P; Volicer L
    Biochem Pharmacol; 1978; 27(19):2333-6. PubMed ID: 215154
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.
    Jori A; Cecchetti G; Dolfini E; Monti E; Garattini S
    Eur J Pharmacol; 1974 Jul; 27(2):245-8. PubMed ID: 4851685
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of striatal acetylcholine concentration by dopamine receptors.
    Sethy VH; Van Woert MH
    Nature; 1974 Oct; 251(5475):529-30. PubMed ID: 4421728
    [No Abstract]   [Full Text] [Related]  

  • 16. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.
    Masuda Y; Murai S; Saito H; Abe E; Fujiwara H; Kohori I; Itoh T
    Neuropharmacology; 1991 Jan; 30(1):35-40. PubMed ID: 2046878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.